Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Guerbet appoints Yves L'Epine CEO

This article was originally published in Scrip

Executive Summary

Guerbet, a pharmaceutical group dedicated to medical imaging, has appointed Dr Yves L'Epine CEO, following the death of the company's former CEO, Bernard Massiot, in May 2011. Dr L'Epine will take up his position at the end of November, and has previously held general management roles at Novartis, Takeda and Abbott.


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts